Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
7.1%
% of WDNA's 90 holdings also in LFSC
21.4%
% of LFSC's 29 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus LFSC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in LFSC |
Overlap | |
|---|---|---|---|---|
 |
BLUEPRINT MEDICINES CORP. | 2.6% | 6.0% | 2.6% |
|
BRIDGEBIO PHARMA, INC. | 2.4% | 7.5% | 2.4% |
|
UNITED THERAPEUTICS CORP | 1.7% | 1.6% | 1.6% |
|
SAREPTA THERAPEUTICS INC | 1.4% | 2.1% | 1.4% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.3% | 4.5% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to LFSC
|
NATERA INC | 3.7% |
|
TWIST BIOSCIENCE CORP. | 3.3% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
VERICEL CORPORATION | 2.6% |
|
VERACYTE INC | 2.1% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
|
GILEAD SCIENCES INC | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
 |
NOVARTIS AG | 1.7% |
WDNA Underweight Relative to LFSC
|
SOLENO THERAPEUTICS INC | -7.6% |
|
RADNET INC | -6.2% |
|
MERIT MEDICAL SYSTEMS INC | -5.4% |
|
BRIDGEBIO PHARMA, INC. | -5.1% |
|
TRANSMEDICS GROUP, INC. | -5.1% |
|
TRAVERE THERAPEUTICS, INC. | -4.7% |
 |
LIVANOVA PLC | -4.7% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -4.5% |
|
INSMED INC | -4.1% |
|
ALPHATEC HOLDINGS INC | -3.9% |